BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value ($000): $586,783 (95.8% shares, 4.2% debt)

Holdings (30)

— BLUEPRINT MEDICINES CORP 10.2%

Value ($000) $60,015 Shares 2,278,459 Est. Cost $26.18 Unrealized —

— CHEMOCENTRYX INC 9.2%

Value ($000) $54,090 Shares 6,677,722 Est. Cost $10.42 Unrealized —

— CTI BIOPHARMA CORP 9.2%

Value ($000) $53,869 Shares 43,795,613 Est. Cost $1.28 Unrealized —

— CONCERT PHARMACEUTICALS INC 7.2%

Value ($000) $42,341 Shares 2,232,014 Est. Cost $13.81 Unrealized —

— ONCOTHYREON INC 7.1%

Value ($000) $41,735 Shares 18,799,368 Est. Cost $2.18 Unrealized —

— VITAE PHARMACEUTICALS INC 6.4%

Value ($000) $37,310 Shares 2,061,325 Est. Cost $10.55 Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 5.8%

Value ($000) $34,028 Shares 2,935,975 Est. Cost $10.04 Unrealized -3.8%

CYTK CYTOKINETICS INC 5.2%

Value ($000) $30,550 Shares 2,920,628 Est. Cost $6.64 Unrealized +47.8%

— ARRAY BIOPHARMA INC 4.8%

Value ($000) $28,201 Shares 6,682,711 Est. Cost $4.56 Unrealized —

— FORWARD PHARMA A/S 4.7%

Value ($000) $27,384 Shares 1,441,287 Est. Cost $20.85 Unrealized —

— ONCOMED PHARMACEUTICALS INC 3.8%

Value ($000) $22,347 Shares 991,433 Est. Cost $21.93 Unrealized —

— EXELIXIS INC 3.8%

Value ($000) $22,187 Shares 18,842,778 Est. Cost $0.81 Unrealized —

— LOXO ONCOLOGY INC 3.4%

Value ($000) $20,230 Shares 711,067 Est. Cost $14.62 Unrealized —

— ARQULE INC 2.5%

Value ($000) $14,777 Shares 6,809,843 Est. Cost $1.91 Unrealized —

— QLT INC 2.4%

Value ($000) $14,269 Shares 5,364,385 Est. Cost $3.71 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 2.2%

Value ($000) $12,707 Shares 608,848 Est. Cost $15.82 Unrealized 0.0%

— TOBIRA THERAPEUTICS INC 2.1%

Value ($000) $12,597 Shares 1,253,401 Est. Cost $16.80 Unrealized —

— FIVE PRIME THERAPEUTICS INC 2.1%

Value ($000) $12,450 Shares 300,000 Est. Cost $41.50 Unrealized —

— NIVALIS THERAPEUTICS INC 1.6%

Value ($000) $9,249 Shares 1,195,013 Est. Cost $7.74 Unrealized —

XENE XENON PHARMACEUTICALS INC 1.5%

Value ($000) $9,050 Shares 1,125,572 Est. Cost $12.47 Unrealized -31.3%

— GTX INC DEL 1.3%

Value ($000) $7,814 Shares 11,163,136 Est. Cost $0.73 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.7%

Value ($000) $4,288 Shares 4,777,381 Est. Cost $0.85 Unrealized —

— PAIN THERAPEUTICS INC 0.6%

Value ($000) $3,242 Shares 1,852,353 Est. Cost $1.79 Unrealized —

— CATALYST BIOSCIENCES INC 0.5%

Value ($000) $3,039 Shares 970,948 Est. Cost $4.66 Unrealized —

GBIM GLOBEIMMUNE INC 0.4%

Value ($000) $2,539 Shares 657,653 Est. Cost $6.22 Unrealized -48.6%

— ARRAY BIOPHARMA INC 0.4%

Value ($000) $2,327 Shares 2,500,000 Est. Cost $1.27 Unrealized —

— MAST THERAPEUTICS INC 0.3%

Value ($000) $1,554 Shares 3,696,961 Est. Cost $0.56 Unrealized —

— CALITHERA BIOSCIENCES INC 0.2%

Value ($000) $1,286 Shares 167,900 Est. Cost $5.43 Unrealized —

— BIOTA PHARMACEUTIALS INC 0.1%

Value ($000) $681 Shares 350,776 Est. Cost $6.11 Unrealized —

— NEPHROGENEX INC 0.1%

Value ($000) $627 Shares 392,156 Est. Cost $1.60 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,278,459	$60,015	10.2%	$26.18	—	COM	09627Y109
—	CHEMOCENTRYX INC	6,677,722	$54,090	9.2%	$10.42	—	COM	16383L106
—	CTI BIOPHARMA CORP	43,795,613	$53,869	9.2%	$1.28	—	COM	12648L106
—	CONCERT PHARMACEUTICALS INC	2,232,014	$42,341	7.2%	$13.81	—	COM	206022105
—	ONCOTHYREON INC	18,799,368	$41,735	7.1%	$2.18	—	COM	682324108
—	VITAE PHARMACEUTICALS INC	2,061,325	$37,310	6.4%	$10.55	—	COM	92847N103
IRWD	IRONWOOD PHARMACEUTICALS INC	2,935,975	$34,028	5.8%	$10.04	-3.8%	COM CL A	46333X108
CYTK	CYTOKINETICS INC	2,920,628	$30,550	5.2%	$6.64	+47.8%	COM NEW	23282W605
—	ARRAY BIOPHARMA INC	6,682,711	$28,201	4.8%	$4.56	—	COM	04269X105
—	FORWARD PHARMA A/S	1,441,287	$27,384	4.7%	$20.85	—	SPONSORED ADR	34986J105
—	ONCOMED PHARMACEUTICALS INC	991,433	$22,347	3.8%	$21.93	—	COM	68234X102
—	EXELIXIS INC	18,842,778	$22,187	3.8%	$0.81	—	NOTE 4.250% 8/1	30161QAC8
—	LOXO ONCOLOGY INC	711,067	$20,230	3.4%	$14.62	—	COM	548862101
—	ARQULE INC	6,809,843	$14,777	2.5%	$1.91	—	COM	04269E107
—	QLT INC	5,364,385	$14,269	2.4%	$3.71	—	COM	746927102
CTMX	CYTOMX THERAPEUTICS INC	608,848	$12,707	2.2%	$15.82	0.0%	COM	23284F105
—	TOBIRA THERAPEUTICS INC	1,253,401	$12,597	2.1%	$16.80	—	COM	88883P101
—	FIVE PRIME THERAPEUTICS INC	300,000	$12,450	2.1%	$41.50	—	COM	33830X104
—	NIVALIS THERAPEUTICS INC	1,195,013	$9,249	1.6%	$7.74	—	COM	65481J109
XENE	XENON PHARMACEUTICALS INC	1,125,572	$9,050	1.5%	$12.47	-31.3%	COM	98420N105
—	GTX INC DEL	11,163,136	$7,814	1.3%	$0.73	—	COM	40052B108
—	SUNESIS PHARMACEUTICALS INC	4,777,381	$4,288	0.7%	$0.85	—	COM NEW	867328601
—	PAIN THERAPEUTICS INC	1,852,353	$3,242	0.6%	$1.79	—	COM	69562K100
—	CATALYST BIOSCIENCES INC	970,948	$3,039	0.5%	$4.66	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$2,539	0.4%	$6.22	-48.6%	COM	37957B100
—	ARRAY BIOPHARMA INC	2,500,000	$2,327	0.4%	$1.27	—	NOTE 3.000% 6/0	04269XAA3
—	MAST THERAPEUTICS INC	3,696,961	$1,554	0.3%	$0.56	—	COM	576314108
—	CALITHERA BIOSCIENCES INC	167,900	$1,286	0.2%	$5.43	—	COM	13089P101
—	BIOTA PHARMACEUTIALS INC	350,776	$681	0.1%	$6.11	—	COM	090694100
—	NEPHROGENEX INC	392,156	$627	0.1%	$1.60	—	COM	640667101